Novartis to acquire Avidity Biosciences for USD 12 billion
Novartis to Acquire Avidity Biosciences for $12 Billion Novartis has announced an agreement to acquire Avidity Biosciences, a biopharmaceutical company focused on RNA delivery to muscle.
Resident doctors begin strike over unmet demands October 31
Resident Doctors Begin Strike Over Unmet Demands The Nigerian Association of Resident Doctors (NARD) will begin an indefinite strike on Fr…
Video of Spanish coup a case of AI imagination | AAP
Video of Spanish Coup: A Case of AI Imagination A video circulating on social media claims to show Spanish soldiers storming the country's…
Australia Accuses Microsoft of Misleading Consumers With AI-Driven 365 Price Hikes
Australia Accuses Microsoft of Misleading Consumers Australia's ACCC has sued Microsoft for allegedly misleading 2.7 million users over AI…